The largest database of trusted experimental protocols

Cellquanti blue cell viability assay kit

Manufactured by BioAssay Systems
Sourced in United States

The CellQuanti-Blue Cell Viability Assay Kit is a laboratory product designed to measure the viability and proliferation of cells. The kit utilizes a colorimetric method for the quantitative determination of viable cells.

Automatically generated - may contain errors

9 protocols using cellquanti blue cell viability assay kit

1

Isolation and Activation of γδ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following reagents and supplies were used for this study. Buffy coat obtained from Research Blood Components (Boston, MA) was the source of the peripheral blood mononuclear cells (PBMCs). K562 cells were from Sigma Aldrich (St. Louis, MO). The FITC-conjugated anti-γδ-TCR (5A6.E91) antibody, pooled human plasma, and BCA assay kit were from Fisher (Waltham, MA). The phycoerythrin-conjugated anti-CD3 (UCHT1) antibody and interferon γ enzyme-linked immunosorbent assay kit were from Biolegend (San Diego, CA). The CellQuanti-Blue Cell Viability Assay Kit was from BioAssay Systems (Hayward, CA). The interleukin 2 and the TCR γ/δ+ T Cell Isolation Kit were from Miltenyi (Bergisch Gladbach, Germany). HMBPP was from Echelon (Salt Lake City, UT). POM2-C-HMBP was synthesized.11 (link)
+ Open protocol
+ Expand
2

Cytotoxicity Assessment of Carbohydrate-Based ILs

Check if the same lab product or an alternative is used in the 5 most similar protocols
In order to evaluate the biocompatibility of the carbohydrate-based ILs cytotoxicity was tested with Cell Viability Assay Kit (BioAssay systems, Hayward, CA, USA).
L929 mouse fibroblasts (CCL-1, ATCC) were cultured in DMEM (PAN BIOTECH, Aidenbach, Germany) with 4.5 mg glucose and 10% fetal calf serum (FCS), 1% Penicillin/Streptomycin and 3.7 g L−1 NaHCO3.
For screening tests 2 × 104 L929 mouse fibroblasts were seeded in a 96-well microtiter plate with 200 μL culture medium per well and incubated under cell culture conditions (37 °C, 5% CO2) for 24 hours.
To proof cell viability CellQuanti-Blue Cell Viability Assay Kit (BioAssay systems, Hayward, CA, USA) was implemented. 10% CellQuanti-Blue supplement was added to the wells followed by an incubation of another 2 hours under same conditions. The reductive activity of the cells conducts the metabolic turnover from resazurin to the fluorescent resorufin (absorption 544 nm, emission 590 nm) which was detected with the Fluostar optima (BMG LABTECH, Ortenberg, Germany).
+ Open protocol
+ Expand
3

OPC Proliferation Assay with T-Cell Secretions

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell numbers were determined using CellQuanti-Blue Cell Viability Assay kit (BioAssay Systems, Hayward, CA) per manufacturer’s instructions. OPCs were plated in 96-well plates in OPC medium and treated with T-cell or HEK293 cell sups (1:20 dilution) for 24 hours at 37°C. CellQuanti-blue reagent (10 μl/well) was added to each well. After incubation for another hour at 37°C, the fluorescence was quantified at an excitation wavelength of 530 nm and emission wavelength of 590 nm using a fluorescence plate reader. Cell proliferation was measured by EdU incorporation assay. After treatment with T-cell sups for 20 hours, OPCs were treated with 10 μM of EdU (Invitrogen) for another 4 hours. The cells were then fixed with 4% paraformaldehyde and EdU labeling was detected using Click-iT EdU Imaging Kits (Invitrogen) per the manufacturer’s instructions. DAPI was used for nuclear staining. Images from seven predetermined fields per well were taken and cell proliferation was determined by calculating the ratio of EdU positive cells to total DAPI positive cells.
+ Open protocol
+ Expand
4

Isolation and Activation of Human γδ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human peripheral blood mononuclear cell (PBMCs) were isolated from buffy coat obtained from Research Blood Components (Boston, MA). K562 cells were from the American Type Culture Collection. The FITC-conjugated anti-γδ-TCR (5A6.E91) antibody and pooled human plasma was purchased from Fisher (Waltham, MA). The phycoerythrin conjugated anti-CD3 (UCHT1) antibody and interferon γ enzyme-linked immunosorbent assay kit were purchased from Biolegend (San Diego, CA). The CellQuanti-Blue Cell Viability Assay Kit was purchased from BioAssay Systems (Hayward, CA). HMBPP was purchased from Echelon (Salt Lake City, UT). The TCRγ/δ+ T Cell Isolation Kit was from Miltenyi (Bergisch Gladbach, Germany). POM2-C-HMBP was synthesized as described previously.9 (link)
+ Open protocol
+ Expand
5

Cellular Proliferation and Viability Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell proliferation was determined using Cell Count Kit-8 (CCK-8, Cat: 40203ES60, YEASEN, Shanghai, China). Cell viability was determined using CellQuanti-Blue Cell Viability Assay Kit (CQBL-05 K, BioAssay systems). About 5000 cells (including RIPK1-knockdown cells GM12878/L428 and RIPK1 overexpression cells TMD8/U2932) were seeded in a 96-well microplate containing a culture growth medium for 12 h. Then, cells were subjected to a cell proliferation/viability assay every 12 h (0, 12, 24, 36, and 48 h) following the manufacturer’s instruction. Each sample was detected with at least three replications.
+ Open protocol
+ Expand
6

Isolation and Activation of Human γδ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human peripheral blood mononuclear cell (PBMCs) were isolated from buffy coat obtained from Research Blood Components (Boston, MA). K562 cells were from Sigma Aldrich (St. Louis, MO). The FITC-conjugated anti-γδ-TCR (5A6.E91) antibody and pooled human plasma were purchased from Fisher (Waltham, MA). The phycoerythrin-conjugated anti-CD3 (UCHT1) antibody and interferon γ enzyme-linked immunosorbent assay kit were purchased from Biolegend (San Diego, CA). The CellQuanti-Blue Cell Viability Assay Kit was purchased from BioAssay Systems (Hayward, CA). The interleukin 2 and the TCR γ/δ+ T Cell Isolation Kit were from Miltenyi (Bergisch Gladbach, Germany). HMBPP was purchased from Echelon (Salt Lake City, UT). POM2-C-HMBP was synthesized as described previously.11 (link)
+ Open protocol
+ Expand
7

Cell Viability Assay on Fibroblasts

Check if the same lab product or an alternative is used in the 5 most similar protocols
L929 mouse fibroblasts (CCL-1, ATCC) were cultured in Dulbeccoʼs Modified Eagle Medium (DMEM, PAN BIOTECH, Aidenbach, Germany) with 4.5 mg Glucose, 10% fetal calf serum (FCS), 1% Penicillin/Streptomycin and 3.7 g/L NaHCO3. 1x104 L929 mouse fibroblasts were seeded directly on the hydrogel specimen with 200 μL culture medium per well and incubated under cell culture conditions (37°C, 5% CO2) for 46 hours (fibroblast cell density 62500 cellsxcm2). To assess relative cell viability, a resazurin based CellQuanti-Blue Cell Viability Assay Kit (BioAssay systems, Hayward, CA, USA) was implemented. 10% CellQuanti-Blue supplement was added to the wells followed by an incubation of another 2 hours under same conditions. The metabolic turnover from resazurin to the fluorescent resorufin (absorption 544 nm, emission 590 nm) was detected with the Fluostar optima (BMG LABTECH, Ortenberg, Germany). Replicates (n ≥ 3) were tested for normal distribution and subjected to a Nalimovs’ test for outliers. Means and standard errors (SEM) were calculated in Sigma Plot.
+ Open protocol
+ Expand
8

Pharmacokinetic Interactions of Uremic Toxins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Camptothecin and SN-38 were purchased from Tokyo Chemical Industry Co., Ltd. (Tokyo, Japan). Ko143 was purchased from Sigma Aldrich Co. LLC (St. Louis, MO, USA). Verapamil and rifampicin were purchased from FUJIFILM Wako Pure Chemical Corporation (Osaka, Japan). Baicalin was purchased from AdooQ Bioscience (Irvine, CA, USA), and Cell Quanti-BlueTM Cell Viability Assay Kit was purchased from Bio Assay Systems (Hayward, CA, USA). All other reagents were of high-purity analytical or high-performance liquid chromatography (HPLC)-grade. Pooled human serum from healthy subjects (normal serum) was purchased from Merck Millipore Ltd. (Billerica, MA, USA), and pooled human serum from patients with ESKD (uremic serum) was obtained from more than 400 patients with ESKD undergoing hemodialysis at Shirasagi Hospital (Osaka, Japan). Blood samples were collected immediately before hemodialysis in a non-invasive manner. Normal and uremic serum were deproteinized by 3-times volume of methanol as much as serum and evaporated under a nitrogen stream at 50 °C; the resulting serum residues, normal serum residue (NSR) and uremic serum residue (USR), were used in the study3 (link). The present study was approved by the ethics committees of Shirasagi Hospital (IRB number J2012013) and Kyoto Pharmaceutical University (IRB number 08-04).
+ Open protocol
+ Expand
9

Butyrate Modulation of LPS-Induced Viability

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sodium butyrate (Sigma-Aldrich, St. Louis, MO) was dissolved in DMEM/F12 to make the butyrate working solution. Cells were treated with butyrate throughout the differentiation period (day 0 to 7). On day 7 post-differentiation, fresh medium was added and cells were challenged with LPS-derived from E. coli O55:B5 (Sigma-Aldrich, St. Louis, MO) at 10 μg/ml. Preliminary experiments were also conducted to determine the optimal butyrate concentration and duration of exposure to LPS to determine effect on cell viability. Analysis of cell viability was performed in 96-well cell culture plates (Corning Inc., Corning, NY) with the use of CellQuanti-BlueTM cell viability assay kit (BioAssay Systems, Hayward, CA), according to the manufacturer’s instruction. The results of pilot experiments indicated that optimal concentrations of butyrate ranged from 0.1 mM to 1 mM because there was no significant adverse effect on cell viability at these concentrations (S1 Fig). Stimulation with LPS at 10 μg/ml LPS did not cause any cytotoxic effects up to 24 h of culture. There were 4 to 6 replicates per experiment.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!